Moehs continuously works to adapt to international regulatory requirements.

Moehs continuously works to adapt to international regulatory requirements.

The internationalization of the group has meant the opening of new markets and with it new challenges for our company.

The constant adaptation to the requirements that each country establishes has become a habitual task within the management carried out by the Moehs team.

Constant work leads us to achieve outstanding milestones in the registration of our products in newly established countries or that are currently adjusting their regulations to a global market. The most recent have been the records of Carvedilol, Lidocaine HCl, Metoprolol Succinate, Metoprolol Tartrate and Bisoprolol fumarate in India.

We are currently running the registration of Lidocaine HCl in Russia. For its part, in China, records have already been made for Bisoprolol, Nifedipine and Metoprolol Succinate, and Lidocaine HCl and Bupivacaine are in the process. Both are important emerging markets for us.

At Moehs we work closely with our clients to keep all their records updated and help them with any new requirements from other countries.

An integral service based on commitment and effort that looks after the interests of our clients.

Find out about our products and services.



Internationalization, Regulations, Products, Customer Service

Leave a Comment

Your email address will not be published. Required fields are marked *